Anuh Pharma Limited (NSE:ANUHPHR)

Anuh Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 27, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	10,559	7,459	12,308	3,990	4,307	4,525
Market Cap Growth	-39.39%	-39.39%	208.46%	-7.36%	-4.82%	54.95%
Enterprise Value	9,932	7,081	11,824	3,486	4,209	4,202
Last Close Price	210.65	149.19	-	-	-	-
PE Ratio	22.30	15.75	20.49	11.03	14.09	15.91
PS Ratio	1.60	1.13	1.90	0.76	0.89	1.05
PB Ratio	3.24	2.29	4.23	1.65	2.02	2.37
P/TBV Ratio	3.24	2.29	4.23	1.66	2.02	2.38
P/FCF Ratio	62.19	43.93	155.62	7.62	15.81	-
P/OCF Ratio	28.44	20.09	95.22	7.40	14.92	-
EV/Sales Ratio	1.50	1.07	1.83	0.66	0.87	0.97
EV/EBITDA Ratio	16.31	11.63	15.74	6.56	8.74	9.54
EV/EBIT Ratio	19.04	13.57	17.68	7.97	11.52	14.23
EV/FCF Ratio	58.49	41.71	149.51	6.66	15.45	-
Debt / Equity Ratio	0.03	0.03	0.01	0.00	0.02	0.07
Debt / EBITDA Ratio	0.18	0.18	0.04	0.02	0.09	0.31
Debt / FCF Ratio	0.64	0.64	0.34	0.02	0.16	-
Asset Turnover	1.39	1.39	1.52	1.40	1.43	1.31
Inventory Turnover	6.66	6.66	6.64	5.34	4.72	4.66
Quick Ratio	1.62	1.62	1.67	1.42	1.23	0.98
Current Ratio	2.11	2.11	2.20	1.91	1.98	1.71
Return on Equity (ROE)	15.34%	15.34%	22.56%	15.90%	15.11%	16.12%
Return on Assets (ROA)	6.85%	6.85%	9.83%	7.27%	6.72%	5.60%
Return on Capital (ROIC)	10.34%	10.34%	15.59%	11.88%	10.81%	8.97%
Return on Capital Employed (ROCE)	15.90%	15.90%	22.80%	17.90%	16.90%	15.30%
Earnings Yield	4.48%	6.35%	4.88%	9.07%	7.10%	6.28%
FCF Yield	1.61%	2.28%	0.64%	13.12%	6.33%	-5.50%
Dividend Yield	-	1.00%	-	-	-	-
Payout Ratio	26.44%	26.45%	16.69%	24.18%	24.73%	-
Buyback Yield / Dilution	0.01%	0.01%	-	-	-	-
Total Shareholder Return	0.01%	1.01%	-	-	-	-

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.